The most common chronic progressive fibrosing ILD is IPF.1,2 PPF is another form of progressive fibrotic lung disease that ...

Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...

Genetic predisposition to rheumatoid arthritis increases the risk of interstitial lung disease by 15.5%, as shown by Mendelian randomization analysis. The study used 52 single nucleotide polymorphisms ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Baylor Medicine’s Interstitial Lung Disease (ILD) program offers specialized and multidisciplinary care. We bring together a unique team of physicians of multiple sub-specialties for patients with a ...

Text Among the spectrum of idiopathic inflammatory myopathies (IIM), two distinct subtypes—anti-synthetase syndrome (ASyS) and anti-MDA5-positive ...

DelveInsight’s, “Interstitial Lung Diseases Pipeline Insight 2023” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Interstitial Lung Disease pipeline ...

Please provide your email address to receive an email when new articles are posted on . Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases. There ...

PD-L1 score as a prognostic biomarker in Asian patients with early-stage, EGFR-mutated lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include ...